Lung cancer, known as one of the leading causes of cancer death worldwide, has seen significant progress in the fight against it in recent years thanks to early detection and the development of innovative treatments. However, medical and social challenges remain, highlighting the importance of prevention and ongoing research.
Advances in the fight against cancer and survival
One of the most significant recent achievements has been the increase in overall five-year survival for early-detected cases, reaching 20%, according to a Roche Pharma report. This percentage rises to 60% when the diagnosis is made in the early stages. These improvements are attributed to:
Early Diagnosis and Screening
One of the major advances has been the implementation of screening programs using low-dose computed tomography (LDCT). Studies have shown that this method reduces lung cancer mortality by 20% in high-risk populations, such as current or former smokers over 55 years of age. This approach allows for the detection of cancer in its early stages, where the five-year survival rate is 60%.
Immunotherapy and Targeted Therapies
Immunotherapy, particularly with immune checkpoint inhibitors (such as nivolumab and pembrolizumab), has transformed the treatment of advanced lung cancer. These therapies help the immune system recognize and attack cancer cells, prolonging patients' lives. On the other hand, targeted therapies are designed to attack specific mutations in tumors, such as alterations in the EGFR, ALK, and ROS1 genes. This approach not only improves treatment efficacy but also reduces side effects by avoiding damage to healthy cells.
Genomic Testing: Personalized Treatment
Genomic testing has been an essential pillar in precision medicine.
These tools identify genetic alterations in tumors that allow:
- Select the most effective targeted treatments.
- Monitor treatment resistance and adapt therapies in real time.
- To anticipate the patient's response to certain medications.
Radiotherapy and Advanced Surgery
Stereotactic body radiation therapy (SBRT) is a high-precision technique that allows for the treatment of localized tumors with concentrated doses, reducing damage to surrounding tissues. In turn, robot-assisted surgeries, such as robotic lobectomy, have improved surgical outcomes by being less invasive and reducing recovery time.
New Models of Care
With increased survival rates, the need has arisen to design care models that prioritize the overall well-being of patients. This includes:
- Pulmonary rehabilitation programs to improve breathing capacity.
- Psychological support to manage disorders such as anxiety and post-traumatic stress.
- Close coordination between specialists and primary care physicians for personalized follow-up.
Late Diagnoses and Persistent Challenges
Despite the progress, significant challenges remain. Sixty percent of lung cancer cases are diagnosed at advanced stages, where five-year survival rates drop to just 3 percent. This underscores the urgent need to improve early detection strategies and access to innovative treatments.
Medical and Social Challenges
The increase in survival has brought with it new challenges:
- Physical consequences: Patients face complications such as chronic fatigue, persistent pain, and difficulty breathing.
- Psychological impact: Approximately 40% of survivors of the % experience emotional disorders such as anxiety, depression, or post-traumatic stress. Psychological care should be an integral part of treatment.
- Medical coordination: Improving communication between specialists and primary care physicians is essential to ensure comprehensive follow-up.
Chronification: A New Reality
The chronic management of lung cancer, where the disease is treated as a long-term condition, represents one of the greatest advances in oncology. However, this new reality presents challenges such as:
- Design care models focused on quality of life.
- Guarantee access to continuous treatments.
- Implement strategies that allow patients to maintain an active and productive life.
Genomic Testing: The Key to Precision Medicine
Genomic testing has revolutionized the way lung cancer is treated. By analyzing the tumor's genetic profile, these tests allow for:
- More accurate diagnoses.
- Identification of targeted therapies.
- Monitoring the evolution of cancer.
At zogen, we facilitate access to next-generation genomic testing that provides vital information to personalize treatments and improve outcomes for lung cancer patients. If you or a family member has received a diagnosis, contact us.
Awareness and Prevention: Our Best Defense
Early detection remains the best strategy for reducing mortality. This month, we urge everyone to prioritize lung health through regular checkups, quitting smoking, and learning about early warning signs, such as:
- Persistent cough.
- Difficulty breathing.
- Chest pain.
The commitment to fighting lung cancer must be shared by everyone. From advances in research to equitable access to quality treatments, every effort counts in changing the landscape of this disease.
